T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com

Stock analysts at StockNews.com initiated coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a note issued to investors on Wednesday. The firm set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

T2 Biosystems stock opened at $0.53 on Wednesday. The firm has a 50-day moving average price of $1.08 and a two-hundred day moving average price of $3.19. T2 Biosystems has a 52-week low of $0.42 and a 52-week high of $8.38.

Institutional Inflows and Outflows

An institutional investor recently raised its position in T2 Biosystems stock. Virtu Financial LLC increased its stake in T2 Biosystems, Inc. (NASDAQ:TTOO) by 29.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 13,096 shares of the medical equipment provider’s stock after purchasing an additional 3,018 shares during the quarter. Virtu Financial LLC owned about 0.24% of T2 Biosystems worth $39,000 at the end of the most recent quarter. Institutional investors own 23.18% of the company’s stock.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.